دورية أكاديمية
أعرض في EDS

Association between tamoxifen and tooth loss in women with breast cancer.

التفاصيل البيبلوغرافية
العنوان: Association between tamoxifen and tooth loss in women with breast cancer.
المؤلفون: de Araujo Sensever F; Franciscan University (UFN), Santa Maria, Brazil., Jardim LC; Franciscan University (UFN), Santa Maria, Brazil., Ferrazzo KL; Department of Pathology, Federal University of Santa Maria (UFSM), Santa Maria, Brazil., Skupien JA; Franciscan University (UFN), Santa Maria, Brazil., Antoniazzi RP; Department of Stomatology, Federal University of Santa Maria (UFSM), Roraima, 1000, Santa Maria, 97015-900, Brazil. raquelantoniazzi@hotmail.com.
المصدر: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2022 Oct; Vol. 30 (10), pp. 8193-8199. Date of Electronic Publication: 2022 Jul 07.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Berlin : Springer International, c1993-
مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Dental Caries*/chemically induced , Dental Caries*/epidemiology , Tooth Loss*/chemically induced , Tooth Loss*/epidemiology, Aged ; Cross-Sectional Studies ; Female ; Humans ; Myeloma Proteins ; Prevalence ; Tamoxifen/adverse effects
مستخلص: Objectives: Investigate the effect of tamoxifen on the occurrence of tooth loss (TL) in breast cancer (BC) survivors.
Methods: A cross-sectional study was conducted with 140 BC survivors using tamoxifen therapy. Sociodemographic, medical, and dental data were evaluated. TL was determined using the M component of the Decayed, Missing and Filled Teeth (DMFT) index. Logistic regression models were run to determine associations between the independent variables and outcome (TL).
Results: Mean TL was 12.96 (SD 8.88). Only three participants had lost no teeth and 10.7% were completely edentulous. Participants who used tamoxifen for more than 1 year had a higher mean missing teeth (13.99 vs. 10.45; P = 0.030). After the adjustments, the occurrence of more than 12 missing teeth was 2.75-fold higher among women who used tamoxifen for more than 1 year (95% CI: 1.06-7.12). Moreover, age over 65 years, referral for treatment by the public healthcare system, less use of dental services, xerostomia, and a lower occurrence of dental caries remained associated with the loss of more than 12 teeth.
Conclusion: Longer use of tamoxifen was associated with greater tooth loss in breast cancer survivors.
Clinical Relevance: Based on estimates of the increase in cases of breast cancer, the prolonged use of tamoxifen for the treatment of this disease can exert an impact on oral health through the occurrence of tooth loss. These findings can contribute to the planning and implementation of oral health care and prevention strategies for such patients.
(© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
References: GBD 2017 Oral Disorders Collaborators Bernabe E, Marcenes W, Hernandez CR et al (2020) Global regional and national levels and trends in burden of oral conditions from 1990 to 2017 a systematic analysis for the global burden of disease 2017 study. J Dent Res 99(4):362-373. doi: https://doi.org/10.1177/0022034520908533.
Houshmand M, Holtfreter B, Berg MH et al (2012) Refining definitions of periodontal disease and caries for prediction models of incident tooth loss. J Clin Periodontol 39(7):635–644. https://doi.org/10.1111/j.1600-051X.2012.01892.x. (PMID: 10.1111/j.1600-051X.2012.01892.x22612722)
Haag DG, Peres KG, Balasubramanian M et al (2017) Oral conditions and health-related quality of life: a systematic review. J Dent Res 96(8):864–874. https://doi.org/10.1177/0022034517709737. (PMID: 10.1177/002203451770973728581891)
Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249. https://doi.org/10.3322/caac.21660. (PMID: 10.3322/caac.2166033538338)
Harbeck N, Gnant M (2017) Breast cancer. Lancet 389(10074):1134–1150. https://doi.org/10.1016/S0140-6736(16)31891-8. (PMID: 10.1016/S0140-6736(16)31891-827865536)
Brinton LA, Gaudet MM, Gierach GL (2018) Breast cancer, cancer epidemiology and prevention p. 861–888.
Łukasiewicz S, Czeczelewski M, Forma A et al (2021) Breast cancer-epidemiology, risk factors, classification, prognostic markers, and current treatment strategies—an updated review. Cancers (Basel) 13(17):4287. https://doi.org/10.3390/cancers13174287. (PMID: 10.3390/cancers13174287)
Runowicz CD, Leach CR, Henry NL et al (2016) American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA Cancer J Clin 66(1):43–73. https://doi.org/10.3322/caac.21319. (PMID: 10.3322/caac.2131926641959)
Epstein JB, Thariat J, Bensadoun RJ et al (2012) Oral complications of cancer and cancer therapy: from cancer treatment to survivorship. CA Cancer J Clin 62(6):400–422. https://doi.org/10.3322/caac.21157. (PMID: 10.3322/caac.2115722972543)
Jardim LC, Flores PT, de Araujo SF et al (2019) Oral lesions and associated factors in breast cancer survivors. J Investig Clin Dent 10(4):e12447. https://doi.org/10.1111/jicd.12447. (PMID: 10.1111/jicd.1244731402601)
Jardim LC, Flores PT, do Carmo Dos Santos Araújo M et al (2020) Oral health-related quality of life in breast cancer survivors. Support Care Cancer 28(1):65–71. https://doi.org/10.1007/s00520-019-04792-3. (PMID: 10.1007/s00520-019-04792-330982094)
Ustaoğlu G, Bulut DG, Üyetürk U et al (2021) Evaluation of periodontal health in breast cancer patients undergoing tamoxifen or aromatase inhibitors drugs therapy a cross-sectional study. Spec Care Dentist Jan; 41(1):41–48. (PMID: 10.1111/scd.12538)
Hong CH, Napeñas JJ, Hodgson BD et al (2010) A systematic review of dental disease in patients undergoing cancer therapy. Support Care Cancer 18(8):1007–1021. https://doi.org/10.1007/s00520-010-0873-2. (PMID: 10.1007/s00520-010-0873-2204497562914291)
Taichman LS, Van Poznak CH, Inglehart MR (2016) Self-reported oral health and quality of life of postmenopausal breast cancer survivors on aromatase inhibitors and women without cancer diagnoses: a longitudinal analysis. Support Care Cancer 24(11):4815–4824. https://doi.org/10.1007/s00520-016-3336-6. (PMID: 10.1007/s00520-016-3336-6274558515614704)
World Health Organization (1997) Oral health surveys. Basic Methods. Geneva: World Health Organization :93.
Nowjack-Raymer RE, Sheiham A (2007) Numbers of natural teeth, diet, and nutritional status in US adults. J Dent Res 86(12):1171–1175. https://doi.org/10.1177/154405910708601206. (PMID: 10.1177/15440591070860120618037650)
Chen QL, Zeng XT, Luo ZX et al (2016) Tooth loss is associated with increased risk of esophageal cancer: evidence from a meta-analysis with dose-response analysis. Sci Rep 6:18900. https://doi.org/10.1038/srep18900.
Shi J, Leng W, Zhao L et al (2017) Tooth loss and cancer risk a dose-response meta analysis of prospective cohort studies. Oncotarget 9(19):15090–15100. https://doi.org/10.18632/oncotarget.23850. (PMID: 10.18632/oncotarget.23850295999295871100)
Loos BG (2005) Systemic markers of inflammation in periodontitis. J Periodontol 76(11 Suppl):2106–2115. https://doi.org/10.1902/jop.2005.76.11-S.2106. (PMID: 10.1902/jop.2005.76.11-S.210616277583)
Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420(6917):860–867. https://doi.org/10.1038/nature01322. (PMID: 10.1038/nature01322124909592803035)
Zhang HP, Cao HY, Yuan AH (2013) The principle and progress of anti-inflammation treatment of gastric cancer. Modern Medical Journal 41(8):605–609.
Shi T, Min M, Sun C et al (2018) Periodontal disease and susceptibility to breast cancer: a meta-analysis of observational studies. J Clin Periodontol 45(9):1025–1033. https://doi.org/10.1111/jcpe.12982. (PMID: 10.1111/jcpe.1298229974484)
Waks AG, Winer EP (2019) Breast cancer treatment: a review. JAMA 321(3):288–300. https://doi.org/10.1001/jama.2018.19323. (PMID: 10.1001/jama.2018.1932330667505)
Davies C, Pan H, Godwin J et al (2013) Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial [published correction appears in Lancet Mar 9;381(9869):804. doi: https://doi.org/10.1016/S0140-6736(12)61963-1 .
Mahesh DR, Komali G, Jayanthi K et al (2014) Evaluation of salivary flow rate, pH and buffer in pre, post & post nenopausal women on HRT. J Clin Diagn Res. 8(2):233–6. https://doi.org/10.7860/JCDR/2014/8158.4067. (PMID: 10.7860/JCDR/2014/8158.4067)
Taichman LS, Havens AM, Van Poznak CH (2013) Potential implications of adjuvant endocrine therapy for the oral health of postmenopausal women with breast cancer. Breast Cancer Res Treat 137(1):23–32. https://doi.org/10.1007/s10549-012-2217-z. (PMID: 10.1007/s10549-012-2217-z22986813)
Taichman LS, Gomez G, Inglehart MR (2015) Oral health-related complications of breast cancer treatment: assessing dental hygienists’ knowledge and professional practice. J Dent Hyg 89(Suppl 2):22–37. (PMID: 263389055614710)
Pedersen AML, Sørensen CE, Proctor GB (2018) Salivary secretion in health and disease. J Oral Rehabil 45(9):730–746. (PMID: 10.1111/joor.12664)
Välimaa H, Savolainen S, Soukka T (2004) Estrogen receptor-beta is the predominant estrogen receptor subtype in human oral epithelium and salivary glands. J Endocrinol. 180(1):55–62. https://doi.org/10.1677/joe.0.1800055. (PMID: 10.1677/joe.0.180005514709144)
Lucisano MP, da Silva RAB, de Sousa Pereira AP (2021) Alteration of the oral microbiota may be a responsible factor, along with estrogen deficiency, by the development of larger periapical lesions. Clin Oral Investig Jun. 25(6):3651–3662. https://doi.org/10.1007/s00784-020-03688-5. (PMID: 10.1007/s00784-020-03688-5)
Streckfus CF, Baur U, Brown LJ et al (1998) Effects of estrogen status and aging on salivary flow rates in healthy Caucasian women. Gerontology 44(1):32–39. https://doi.org/10.1159/000021980. (PMID: 10.1159/0000219809436013)
Mosel DD, Bauer RL, Lynch DP et al (2011) Oral complications in the treatment of cancer patients. Oral Dis 17(6):550–559. https://doi.org/10.1111/j.1601-0825.2011.01788.x. (PMID: 10.1111/j.1601-0825.2011.01788.x21306481)
Kim S, Park S, Lin M (2017) Permanent tooth loss and sugar-sweetened beverage intake in U.S. young adults. J Public Health Dent. 77(2):148–154. https://doi.org/10.1111/jphd.12192. (PMID: 10.1111/jphd.1219227886383)
Matos DL, Lima-Costa MF, Guerra HL (2002) Bambuí Project: an evaluation of private, public and unionized dental services. Rev Saude Publica 36(2):237–243. https://doi.org/10.1590/s0034-89102002000200017. (PMID: 10.1590/s0034-8910200200020001712045806)
Unfer B, Saliba O (2000) Evaluate of popular knowledge and everyday practices in oral health. Rev Saude Publica 34(2):190–195. https://doi.org/10.1590/s0034-89102000000200014. (PMID: 10.1590/s0034-8910200000020001410881156)
Srivastava P, Chen G, Harris A (2017) Oral health, dental insurance and dental service use in Australia. Health Econ 26(1):35–53. https://doi.org/10.1002/hec.3272. (PMID: 10.1002/hec.327226449483)
فهرسة مساهمة: Keywords: Breast cancer; Dental caries; Oral health; Tamoxifen; Tooth extraction
المشرفين على المادة: 0 (Myeloma Proteins)
094ZI81Y45 (Tamoxifen)
تواريخ الأحداث: Date Created: 20220707 Date Completed: 20220928 Latest Revision: 20220928
رمز التحديث: 20231215
DOI: 10.1007/s00520-022-07271-4
PMID: 35796887
قاعدة البيانات: MEDLINE
الوصف
تدمد:1433-7339
DOI:10.1007/s00520-022-07271-4